文献速递神经肿瘤

利用微小RNA谱识别高复发风险脑膜瘤患者

Identification of Meningioma Patients at High Risk of Tumor Recurrence Using MicroRNA Profiling.
PubMed 文献 · Neurosurgery · 2020-01-01

该研究通过微阵列筛选不同WHO级别原发和复发脑膜瘤的微小RNA表达,并在172例患者队列中验证,发现miR-331-3p低表达(HR 1.44;P < .001)和肿瘤部分切除(HR 3.90;P < .001)是最具预测性的复发模型,模型可能更准确预测脑膜瘤复发时间并指导术后管理。

要点

  • miR-331-3p低表达与脑膜瘤复发风险升高相关(HR 1.44;P < .001)。
  • 肿瘤部分切除是复发的重要预测因素(HR 3.90;P < .001)。
  • 在全部切除亚组中,两种微小RNA在调整临床因素的单变量模型中仍为预后因素。

核心结论

  • 所提出的模型可能更准确预测脑膜瘤复发时间,从而确定最佳术后管理。
  • 将模型与现有复发分子机制知识结合,可能识别不同脑膜瘤亚型并实现更好的靶向治疗。

研究设计与样本

  • 微阵列鉴定所有WHO级别原发和复发脑膜瘤的微小RNA表达,差异表达者在一172例患者队列中通过定量实时聚合酶链反应验证。
  • 对所得数据集进行统计分析,揭示脑膜瘤复发的预测因素。

主要发现

  • 调整和非调整的复发时间模型确定最显著的预后因素为miR-15a-5p、miR-146a-5p和miR-331-3p。
  • 最终验证阶段证明miR-146a-5p和miR-331-3p以及切除类型(全部或部分)和WHO级别在某些选定模型中的关键意义。
  • 在扩大队列的多变量模型中逐步选择后,最具预测性的模型包括miR-331-3p低表达(HR 1.44;P < .001)和肿瘤部分切除(HR 3.90;P < .001)。
  • 在全部切除亚组中,两种微小RNA在调整临床因素的单变量模型中仍为预后因素。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Meningioma growth rates are highly variable, even within benign subgroups, with some remaining stable, whereas others grow rapidly. OBJECTIVE: To identify molecular-genetic markers for more accurate prediction of meningioma recurrence and better-targeted therapy. METHODS: Microarrays identified microRNA (miRNA) expression in primary and recurrent meningiomas of all World Health Organization (WHO) grades. Those found to be deregulated were further validated by quantitative real-time polymerase chain reaction in a cohort of 172 patients. Statistical analysis of the resulting dataset revealed predictors of meningioma recurrence. RESULTS: Adjusted and nonadjusted models of time to relapse identified the most significant prognosticators to be miR-15a-5p, miR-146a-5p, and miR-331-3p. The final validation phase proved the crucial significance of miR-146a-5p and miR-331-3p, and clinical factors such as type of resection (total or partial) and WHO grade in some selected models. Following stepwise selection in a multivariate model on an expanded cohort, the most predictive model was identified to be that which included lower miR-331-3p expression (hazard ratio [HR] 1.44; P < .001) and partial tumor resection (HR 3.90; P < .001). Moreover, in the subgroup of total resections, both miRNAs remained prognosticators in univariate models adjusted to the clinical factors. CONCLUSION: The proposed models might enable more accurate prediction of time to meningioma recurrence and thus determine optimal postoperative management. Moreover, combining this model with current knowledge of molecular processes underpinning recurrence could permit the identification of distinct meningioma subtypes and enable better-targeted therapies.

来源:Neurosurgery,查看原文。版权归原作者所有。

引用

  1. Slavik H, Balik V, Vrbkova J, et al. Identification of Meningioma Patients at High Risk of Tumor Recurrence Using MicroRNA Profiling. Neurosurgery. 2020. PMID: 32125436. doi:10.1093/neuros/nyaa009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。